Liu, WM; Fowler, DW; Smith, P; Dalgleish, AG (2010) Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. BRITISH JOURNAL OF CANCER, 102 (1). 115 - 123 (9). ISSN 0007-0920 https://doi.org/10.1038/sj.bjc.6605465
SGUL Authors: Dalgleish, Angus George Liu, Wai Man

Preview

["document_typename_application/pdf; charset=binary" not defined] Published Version Download (756kB) | Preview

Item Type:	Article
Additional Information:	PubMed ID: 19997099
Keywords:	Animals, Antigen Presentation, Antineoplastic Agents, Carcinoma, Cell Line, Tumor, Colonic Neoplasms, Culture Media, Conditioned, Cyclophosphamide, Cytokines, Cytotoxicity, Immunologic, Dendritic Cells, Deoxycytidine, Female, Gene Expression Regulation, Neoplastic, HLA-A1 Antigen, Humans, Lymphocyte Activation, Male, Mice, Mice, Nude, Organoplatinum Compounds, Premedication, T-Lymphocytes, Cytotoxic, Science & Technology, Life Sciences & Biomedicine, Oncology, immunotherapy, HLA1, chemotherapy, dendritic cells, immunovisibility, DENDRITIC CELLS, HLA EXPRESSION, MTT ASSAYS, CANCER, CYCLOPHOSPHAMIDE, SYSTEM, INFLAMMATION, GEMCITABINE, CHEMOIMMUNOTHERAPY, IDENTIFICATION, immunotherapy, HLA1, chemotherapy, dendritic cells, immunovisibility
SGUL Research Institute / Research Centre:	Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title:	BRITISH JOURNAL OF CANCER
ISSN:	0007-0920
Related URLs:	Author
Dates:	Date Event 5 January 2010 Published
Web of Science ID:	WOS:000273563800016
	Download EPMC Full text (PDF)
	Download EPMC Full text (HTML)
URI:	https://openaccess.sgul.ac.uk/id/eprint/258
Publisher's version:	https://doi.org/10.1038/sj.bjc.6605465

Actions (login required)

Edit Item